In a cohort of 62 patients with HCC there were 141 sessions of TACE with DEB loaded with doxorubicin. [56] At 9 months of follow-up, the sustained objective response (European Association for the ...
However, evaluation of novel techniques, such as DEB loaded with doxorubicin in an animal ... common approach for the management of hepatocellular carcinoma (HCC) without curative options.
Differences in mechanisms of action between paclitaxel, doxorubicin and cisplatin in breast cancer may be accompanied by a corresponding diversity in gene expression patterns. We analyzed gene ...
To assess whether there are differences in the mechanism of drug resistance by ... treated with or selected for resistance to doxorubicin. Expression profiles of the human breast carcinoma MCF ...